IDEAYA Biosciences Inc.
IDYA | NASDAQ
$39.55
+$0.69 (+1.78%)
Sep 22, 2026, 12:11 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 234.13M | 225.27M | 218.71M | 214.83M | 7M | 7M | 7M | 3.92M | 11.96M | 15.51M | 23.39M | 23.48M | 45.15M | 47.45M | 50.93M | 49.87M | 29.15M | 32.05M | 27.94M | 35.55M | 35.54M | 26.79M |
Cost of Revenue | 170.74M | 244.96M | 314.7M | 228.75M | 146.77M | 73.64M | 3.83M | 4.22M | 4.19M | 4.09M | 3.97M | 3.5M | 3.44M | 3.65M | 3.15M | 3.02M | 17.6M | 31.37M | 42.47M | 42.41M | 27.19M | 12.61M |
Gross Profit | 63.39M | -19.69M | -95.99M | -13.91M | -139.77M | -66.64M | 3.17M | -292K | 7.77M | 11.42M | 19.42M | 19.98M | 41.7M | 43.81M | 47.78M | 46.85M | 11.55M | 683K | -14.53M | -6.86M | 8.35M | 14.17M |
Operating Income | -216.95M | -183.47M | -159.31M | -208.88M | -384.23M | -360.35M | -326.98M | -224.75M | -191.39M | -159.17M | -134.43M | -118.96M | -84.77M | -74.56M | -62.5M | -54.43M | -66.8M | -55.35M | -50.27M | -37.18M | -30.46M | -32M |
Interest Income | 32.09M | 43.41M | 45.62M | 48.14M | 52.42M | 53.26M | 52.5M | 46.63M | 37.65M | 30.27M | 21.47M | 15.75M | 10.62M | 6.28M | 3.85M | 1.76M | 938K | 599K | 506K | 494K | 433K | 528K |
Pretax Income | -175.02M | -140.06M | -112.93M | -159.96M | -331.03M | -306.31M | -274.48M | -178.12M | -153.74M | -128.89M | -112.96M | -103.21M | -74.15M | -68.28M | -58.66M | -52.67M | -65.86M | -54.75M | -49.76M | -36.69M | -30.03M | -31.47M |
Net Income | -175.02M | -140.06M | -112.93M | -159.96M | -331.03M | -306.31M | -274.48M | -178.12M | -153.74M | -128.89M | -112.96M | -103.21M | -74.15M | -68.28M | -58.66M | -52.67M | -65.86M | -54.75M | -49.76M | -36.69M | -30.03M | -31.47M |
Selling & General & Admin | 77.07M | 69.19M | 63.32M | 54.78M | 47.12M | 41.84M | 35.47M | 31.2M | 29.35M | 26.13M | 24.34M | 23.49M | 22.35M | 20.63M | 20.75M | 20.35M | 19.29M | 19.37M | 18.35M | 16.99M | 15.94M | 15.11M |
Research & Development | 374.01M | 339.54M | 314.7M | 368.29M | 342.45M | 322.75M | 294.67M | 193.26M | 169.81M | 144.45M | 129.51M | 115.45M | 104.12M | 97.74M | 89.54M | 80.93M | 74.06M | 66.25M | 58.16M | 54.1M | 48.62M | 42.24M |
Other Expenses | -170.74M | -244.96M | -314.7M | -228.11M | -145.11M | -70.89M | n/a | n/a | n/a | n/a | n/a | -1K | -1K | -1K | -1K | n/a | -15M | -29.58M | -40.77M | -40.77M | -25.76M | -11.18M |
Operating Expenses | 280.35M | 163.78M | 63.32M | 194.97M | 244.46M | 293.71M | 330.14M | 224.46M | 199.16M | 170.58M | 153.85M | 138.94M | 126.47M | 118.37M | 110.28M | 101.28M | 78.35M | 56.04M | 35.74M | 30.32M | 38.8M | 46.16M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 451.08M | 408.74M | 378.02M | 423.72M | 391.23M | 367.35M | 333.98M | 228.68M | 203.35M | 174.67M | 157.82M | 142.44M | 129.92M | 122.01M | 113.43M | 104.3M | 95.95M | 87.41M | 78.21M | 72.73M | 66M | 58.79M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 92.06M | 88.7M | 88.58M | 89.66M | 88.47M | 88.36M | 87.34M | 86.19M | 77.96M | 75.11M | 65.25M | 60M | 56.25M | 48.37M | 48.13M | 40.3M | 38.66M | 38.59M | 38.36M | 37.36M | 32.85M | 31.76M |
Shares Outstanding (Diluted) | 92.06M | 88.7M | 88.58M | 89.69M | 88.47M | 88.36M | 87.34M | 86.19M | 77.96M | 75.11M | 65.25M | 60M | 56.25M | 48.37M | 48.13M | 41.11M | 38.66M | 38.59M | 38.5M | 37.77M | 32.85M | 31.76M |
EPS (Basic) | -1.92 | -1.58 | -1.29 | -1.84 | -3.79 | -3.59 | -3.30 | -2.33 | -2.19 | -2.01 | -1.89 | -1.83 | -1.31 | -1.37 | -1.43 | -1.44 | -1.81 | -1.58 | -1.39 | -1.10 | -0.96 | -1.22 |
EPS (Diluted) | -1.94 | -1.60 | -1.31 | -1.86 | -3.79 | -3.59 | -3.30 | -2.33 | -2.19 | -2.01 | -1.89 | -1.83 | -1.31 | -1.37 | -1.43 | -1.44 | -1.81 | -1.58 | -1.39 | -1.10 | -0.96 | -1.22 |
EBITDA | -169.39M | -135.46M | -108.33M | -155.93M | -327.01M | -302.43M | -270.64M | -173.91M | -149.55M | -124.8M | -108.99M | -99.71M | -70.71M | -64.64M | -55.5M | -49.65M | -63.27M | -52.97M | -48.06M | -35.04M | -28.59M | -30.03M |
EBIT | -175.02M | -140.06M | -112.93M | -159.96M | -331.03M | -306.31M | -274.48M | -178.12M | -153.74M | -128.89M | -112.96M | -103.21M | -74.15M | -68.28M | -58.66M | -52.67M | -65.86M | -54.75M | -49.76M | -36.69M | -30.03M | -31.47M |
Depreciation & Amortization | 5.63M | 4.6M | 4.59M | 4.04M | 4.02M | 3.89M | 3.83M | 4.22M | 4.19M | 4.09M | 3.97M | 3.5M | 3.44M | 3.65M | 3.15M | 3.02M | 2.59M | 1.79M | 1.71M | 1.64M | 1.44M | 1.44M |
Add to Watchlist
Select watchlists to add or remove IDYA